Literature DB >> 16646590

Role of connexins in atrial fibrillation.

Stefan Dhein1.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in humans. AF is accompanied by a remodeling process which changes the electrophysiology of the cells and the gap junctional communication within the tissue. Gap junctions, forming communicating channels between neighboring cells, and their specific geometric arrangement seem to contribute to the initiation of AF within the pulmonary veins as well as to the stabilization of AF providing a heterogeneous biophysical network of cells enabling multiple wavelets. These tissue changes are accompanied by fibrosis and changes in the expression levels of Cx43 and Cx40, probably depending on the underlying diseases or the animal model used. New studies point to a modulating role of angiotensin II in this process and a possible therapeutic role for ACE inhibitors or AT(1) antagonists.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646590     DOI: 10.1159/000092568

Source DB:  PubMed          Journal:  Adv Cardiol        ISSN: 0065-2326


  9 in total

Review 1.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

Review 2.  Serine/Threonine Phosphatases in Atrial Fibrillation.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Xander H T Wehrens; Dobromir Dobrev
Journal:  J Mol Cell Cardiol       Date:  2017-01-07       Impact factor: 5.000

Review 3.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 4.  Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation.

Authors:  Jason Pellman; Robert C Lyon; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2009-09-12       Impact factor: 5.000

5.  Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis.

Authors:  Takashi Mayama; Ken Matsumura; Hai Lin; Koichi Ogawa; Issei Imanaga
Journal:  Exp Clin Cardiol       Date:  2007

Review 6.  The role of extracellular matrix in age-related conduction disorders: a forgotten player?

Authors:  Cristiano Spadaccio; Alberto Rainer; Pamela Mozetic; Marcella Trombetta; Robert A Dion; Raffaele Barbato; Francesco Nappi; Massimo Chello
Journal:  J Geriatr Cardiol       Date:  2015-01       Impact factor: 3.327

7.  Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats.

Authors:  Namsik Yoon; Kye Hun Kim; Keun Ho Park; Doo Sun Sim; Hyun Ju Youn; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  Korean Circ J       Date:  2013-10-30       Impact factor: 3.243

Review 8.  New Insights on the Role of Connexins and Gap Junctions Channels in Adipose Tissue and Obesity.

Authors:  Jorge Enrique González-Casanova; Samuel Durán-Agüero; Nelson Javier Caro-Fuentes; Maria Elena Gamboa-Arancibia; Tamara Bruna; Valmore Bermúdez; Diana Marcela Rojas-Gómez
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

9.  Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure.

Authors:  Namsik Yoon; Jeong Gwan Cho; Kye Hun Kim; Keun Ho Park; Doo Sun Sim; Hyun Ju Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jong Chun Park
Journal:  Exp Ther Med       Date:  2013-01-23       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.